Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Optimizing maturity and dose of iPSC-derived dopamine progenitor cell therapy for Parkinson's disease.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Optimizing maturity and dose of iPSC-derived dopamine progenitor cell therapy for Parkinson's disease.
Optimizing maturity and dose of iPSC-derived dopamine progenitor cell therapy for Parkinson's disease. NPJ Regen Med. 2022 Apr 21; 7(1):24.
View in:
PubMed
authors with profiles
Jeffrey Kordower